Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.
Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.
复制标题
高胆固醇血症心肌易受缺血再灌注损伤且难以抵抗七氟烷诱导的保护
DOI:
10.1371/journal.pone.0076652
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Wang JA
中科院分区:
文献类型:
--
作者:
Xu Y;Ma LL;Zhou C;Zhang FJ;Kong FJ;Wang WN;Qian LB;Wang CC;Liu XB;Yan M;Wang JA
Recent studies have demonstrated that volatile anesthetic postconditioning confers myocardial protection against ischemia-reperfusion (IR) injury through activation of the reperfusion injury salvage kinase (RISK) pathway. As RISK has been shown to be impaired in hypercholesterolemia. Therefore, we investigate whether anesthetic-induced cardiac protection was maintained in hypercholesterolemic rats. In the present study, normocholesteolemic or hypercholesterolemic rat hearts were subjected to 30 min of ischemia and 2 h of reperfusion. Animals received 2.4% sevoflurane for 5 min or 3 cycles of 10-s ischemia/10-s reperfusion. The hemodynamic parameters, including left ventricular developed pressure, left ventricular end-diastolic pressure and heart rate, were continuously monitored. The infarct size, apoptosis, p-Akt, p-ERK1/2, p-GSK3β were determined. We found that both sevoflurane and ischemic postconditioning significantly improved heart pump function, reduced infarct size and increased the phosphorylation of Akt, ERK1/2 and their downstream target of GSK3β in the healthy rats. In the hypercholesterolemic rats, neither sevoflurane nor ischemic postconditioning improved left ventricular hemodynamics, reduced infarct size and increased the phosphorylated Akt, ERK1/2 and GSK3β. In contrast, GSK inhibitor SB216763 conferred cardioprotection against IR injury in healthy and hypercholesterolemic hearts. In conclusions, hyperchoesterolemia abrogated sevoflurane-induced cardioprotection against IR injury by alteration of upstream signaling of GSK3β and acute GSK inhibition may provide a novel therapeutic strategy to protect hypercholesterolemic hearts against IR injury.
登录
查看更多内容
影响因子:
9.5
作者:
Mykytenko, James;Kerendi, Faraz;Zhao, Zhi-Qing
通讯作者:
Zhao, Zhi-Qing
影响因子:
4.8
作者:
HORTON, JD;CUTHBERT, JA;SPADY, DK
通讯作者:
SPADY, DK
DOI:
10.1152/ajpheart.00484.2009
发表时间:
2009-11-01
影响因子:
4.8
作者:
Kupai, Krisztina;Csonka, Csaba;Ferdinandy, Peter
通讯作者:
Ferdinandy, Peter
影响因子:
37.8
作者:
Ballantyne, CM;Houri, J;Veltri, EP
通讯作者:
Veltri, EP
影响因子:
37.8
作者:
Cao, Chun-Mei;Zhang, Yan;Xiao, Rui-Ping
通讯作者:
Xiao, Rui-Ping